| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.54 | 0.06 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |